Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers.

In a double-blind, placebo-controlled study, self-administered intranasal human interferon alpha A produced by recombinant DNA technology was given both before and after virus challenge with a respiratory coronavirus. The incidence of colds, the severity of symptoms and signs, and virus replication...

Celý popis

Podrobná bibliografie

Vydáno v:	Antimicrob Agents Chemother
Hlavní autoři:	Higgins, P G, Phillpotts, R J, Scott, G M, Wallace, J, Bernhardt, L L, Tyrrell, D A
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 1983
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185930/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6318655/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.24.5.713
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!